PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-May-2026 Takeda annonce les premiers résultats positifs d’un essai clinique pivot de phase 2/3 sur le TAK-881 dans le traitement des déficits immunitaires primaires (DIP) Businesswire
06-May-2026 Takeda宣布針對原發性免疫缺陷病(PID)開發的新藥TAK-881在二/三期臨床試驗中取得正面頂線結果 Businesswire
06-May-2026 Takeda宣布其用于治疗原发性免疫缺陷病(PID)的TAK-881关键性Ⅱ/Ⅲ期临床试验取得积极顶线结果 Businesswire
06-May-2026 Interim Report January - March 2026 ACCESS Newswire
06-May-2026 Faron Pharmaceuticals Ltd: Termination of Liquidity Provision Service ACCESS Newswire
06-May-2026 IRLAB Publishes Interim Report for The Period January - March 2026 ACCESS Newswire
06-May-2026 Investor Notice: Robbins LLP Informs Investors of the Immutep Limited Class Action Businesswire
05-May-2026 Everus Reports First Quarter 2026 Results, Raises Guidance for 2026 Businesswire
05-May-2026 Celanese Corporation Reports First Quarter Earnings Businesswire
05-May-2026 Advicenne Announces the Opening of a Safeguard Proceedings to Restructure Its Financial Liabilities and Finalize the Extension of Its Cash Runway Businesswire
05-May-2026 Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update Businesswire
05-May-2026 Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock Businesswire
05-May-2026 AdaptHealth Corp. to Participate in Upcoming Investor Conferences Businesswire
05-May-2026 Schrödinger Reports First Quarter 2026 Financial Results Businesswire
05-May-2026 Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference Businesswire
05-May-2026 Contineum Therapeutics Reports First-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones Businesswire
05-May-2026 Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update Businesswire
05-May-2026 Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
05-May-2026 FSK Class Action Lawsuit Alert: FS KKR Capital has been Sued for Securities Fraud after 15% Stock Drop Resulting from Net Asset Revelation -- Investors Notified to Contact BFA Law Businesswire
05-May-2026 Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation ACCESS Newswire